Previous Meetings

GBCC 2025

Global Breast Cancer Conference 2025

08:00-08:45
Satellite Symposium 3
Room 1 (Vista 1+2)
Moderators
  • Hyeong-Gon Moon (Seoul National Univ. Hospital, Korea)
Speakers
  • Transforming HR+/HER2- Breast Cancer Care with Ribociclib: A Clinical Perspective
    Sherene Loi (Univ. of Melbourne, Australia)
09:00-10:15
Special Session

GBCC’s Outstanding Oral Presentation 1

Room 1 (Vista 1+2)
Moderators
  • Seho Park (Yonsei Univ. College of Medicine, Korea)
  • In Hae Park (Korea Univ. Guro Hospital, Korea)
Speakers
  • Contributing Factors of Contralateral Breast Cancer Among Breast Cancer Patients with BRCA Mutation (KoREa-BSG 06-2)
    Chihwan David Cha (Hanyang Univ. College of Medicine, Korea)
  • Pathogenic Variant frequency in Multi-gene Panel Testing of Germline BRCA-negative Breast Cancer Patients with Hereditary Risk Factors
    Seung Ho Baek (Yongin Severance Hospital, Korea)
  • Discussion for Abstract AAA001 and AAA002
    Stephanie M. Wong (Jewish General Hospital Segal Cancer Centre, Canada)
  • Joint Label-Guided Analysis of Tumor microenvironment Causality and Clinical outcomes in Breast Cancer Using Multisequence MRI and Artificial Intelligence
    Ni Chao (Second Affiliated Hospital, School of Medicine, Zhejiang Univ., China)
  • Re-evaluation of HER2 Pathology and the Prognostic Implications of HER2 Ultra-low and Low in Estrogen Receptor-Positive Breast Cancer
    Young-Jin Lee (ASAN Medical Center, Korea)
  • Discussion for Abstract AAA003 and AAA004
    Jiwon Koh (Seoul National Univ. Hospital, Korea)
Panel Discussion 4

Integrative Approaches in Local Control for Breast Cancer

Room 2 (Grand 1)
Moderators
  • Woochul Noh (Konkuk Univ. Medical Center, Korea)
  • Judy Boughey (Mayo Clinic, U.S.A.)
Speakers
  • Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer
    Judy Boughey (Mayo Clinic, U.S.A.)
  • Axillary Management According to the Subtype
    E. Shelley Hwang (Duke Univ. School of Medicine, U.S.A.)
  • Immediate Reconstruction After Ipsilateral Breast Recurrence
    Jai Min Ryu (Samsung Medical Center, Korea)
Symposium 7

Salvage Treatment for Locoregional Recurrence

Room 3 (Walker 1)
Moderators
  • Suzy Kim (SMG-SNU Boramae Medical Center, Korea)
  • Jean-Michel Hannoun-Levi (Antoine Lacassagne Cancer Center, France)
Speakers
  • Enhancing Local Treatment Strategies: Innovation and Challenges
    Jong-Ho Cheun (SMG-SNU Boramae Medical Center, Korea)
  • Salvage Reirradiation for In-Breast Recurrence
    Jean-Michel Hannoun-Levi (Antoine Lacassagne Cancer Center, France)
  • Management for Non-Axillary Regional Recurrence
    Chikako Yamauchi (Shiga General Hospital, Japan)
Nursing Session 1 (Kor.)

Comprehensive Patient Care for ABC Patients Treated with Radiotherapy

Room 4 (Walker 2)
Moderators
  • Nayeon Kim (Samsung Medical Center, Korea)
  • Byonghee Jeon (Yonsei Univ. Severance Hospital, Korea)
Speakers
  • Breast Reconstruction and Radiation Therapy: From Breast Cancer Patient Perspective
    Hyungran Lee (Kyung Hee Univ., Korea)
  • Use of Radiotherapy in Advanced Breast Cancer: The Role of a Nurse
    Hye Sung Moon (Ewha Womans Univ. Mokdong Hospital, Korea)
  • Patient Education for Breast Cancer Patients Undergoing Radiation Therapy
    Byunghee Son (Yonsei Cancer Center, Korea)
GBCC-TBCS Joint Session

Breast Cancer Research in Two Technology Powerhouses: Korea and Taiwan

Room 5 (Art Hall)
Moderators
  • Yoo Seok Kim (Chosun Univ. Hospital, Korea)
  • Chi-Cheng Huang (Taipei Veterans General Hospital, Taiwan)
Speakers
  • Big Data Analysis of Electronic Health Records for Breast Cancer Patients
    Jung Eun Choi (Yeungnam Univ. Medical Center, Korea)
  • Big Data Analysis of National Healthcare Data for Breast Cancer
    Il-Yong Chung (ASAN Medical Center, Korea)
  • AI-Powered Research of Breast Cancer
    Han Fang Cheng (Taipei Veterans General Hospital, Taiwan)
  • Balancing Privacy Regulations and Data Utilization in Breast Cancer Research
    Yi-Hsin Yang (National Health Research Institute, Taiwan)
10:30-11:45
Special Session

GBCC’s Outstanding Oral Presentation 2

Room 1 (Vista 1+2)
Moderators
  • Hee Jeong Kim (ASAN Medical Center, Korea)
  • Kyung-Hun Lee (Seoul National Univ. Hospital, Korea)
Speakers
  • Adherence to Adjuvant Tamoxifen Among Premenopausal Patients with Breast Cancer in the ASTRRA Trial
    Soo Yeon Baek (Ajou Univ. Hospital, Korea)
  • Clinical and Translational Study for the Strategy Optimization of Neoadjuvant Endocrine Therapy in HR+/HER2- Breast Cancer
    Zhao Bi (Shandong Cancer Hospital & Institute, China)
  • Discussion for Abstract AAA005 and AAA006
    Hiroji Iwata (Nagoya City Univ., Japan)
  • Accuracy of OPTIMIST Trial criteria in Predicting Pathologic Complete Response Following Neoadjuvant Systemic Therapy
    Jayme Natasha Paggao (Univ. of the East Ramon Magsaysay Memorial Medical Center, Philippines)
  • Redefining Criteria for Omitting Axillary Surgery Following Neoadjuvant Systemic Therapy in Patients with Breast Cancer
    Jijung Jung (Seoul National Univ. Hospital, Korea)
  • Discussion for Abstract AAA007 and AAA008
    Bruce Mann (The Royal Women's Hospital, Australia)
Panel Discussion 5

Collaborative Strategies for Brain Metastases in Breast Cancer

Room 2 (Grand 1)
Moderators
  • Gun Min Kim (Yonsei Univ. College of Medicine, Korea)
  • Nancy Lin (Dana-Farber Cancer Institute, U.S.A.)
Speakers
  • Screening or Early Detection of Brain Metastases and the Treatment in the Era of New Agents
    Nancy Lin (Dana-Farber Cancer Institute, U.S.A.)
  • Recent Update on Neurosurgical Management of Breast Cancer Brain Metastasis
    Young Zoon Kim (Sungkyunkwan Univ. School of Medicine, Korea)
  • Novel Radiotherapeutic Strategies in Brain Metastases: Including New Perspectives in the Era of ADCs and Immunotherapy
    Yutaro Koide (Aichi Cancer Center Hospital, Japan)
Education Session 3

Optimal Surgical Treatment for Early to Advanced BC

Room 3 (Walker 1)
Moderators
  • Tae Hyun Kim (Inje Univ. Busan Paik Hospital, Korea)
  • Tadahiko Shien (Okayama Univ. Hospital, Japan)
Speakers
  • Pathological Features, Breast Cancer Risk and Optimal Treatment in LCIS
    Jiwon Koh (Seoul National Univ. Hospital, Korea)
  • Surgical Controversies in Inflammatory Breast Cancer
    Tristen Park (Mount Sinai Hospital, U.S.A.)
  • Surgical Controversies in De Novo Metastatic Breast Cancer
    Tadahiko Shien (Okayama Univ. Hospital, Japan)
Nursing Session 2 (Kor.)

Motherhood in Breast Cancer Survivor: Challenges and Opportunities

Room 4 (Walker 2)
Moderators
  • Insook Lee (Changwon National Univ., Korea)
  • Sue Kim (Yonsei Univ., Korea)
Speakers
  • Motherhood and Pregnancy Planning Among Young Breast Cancer Survivors
    Jeonghee Ahn (Hanyang Univ. College of Nursing, Korea)
  • Experience in Running a Vitality Recovery Program for Couples with Women’s Cancer: Focusing on Breast Cancer
    Eun-Young Jun (Daejeon Univ., Korea)
  • Psychosocial Intervention for Children of Breast Cancer Patients
    Eunkyung Hwang (Seoul National Univ. Hospital, Korea)
GBCC-JBCS Joint Session

JAPAN-KOREA Breast Cancer Research International Dialogue for Global Excellence (J-K BRIDGE)

Room 5 (Art Hall)
Moderators
  • Jun Won Min (Dankook Univ. Hospital, Korea)
  • Fumikata Hara (Aichi Cancer Center, Japan)
Speakers
  • Data on BRCA in Korea
    Chihwan David Cha (Hanyang Univ. College of Medicine, Korea)
  • Data on BRCA in Japan
    Kumiko Kida (St. Luke's International Hospital, Japan)
  • Fertility Preservation Survey Study
    Young-Jin Lee (ASAN Medical Center, Korea)
  • Surgical Trends in Korea
    Jeeyeon Lee (Kyungpook National Univ. Chilgok Hospital, Korea)
  • Surgical Trends in Japan
    Hitomi Mori (Japanese Red Cross Fukuoka Hospital, Japan)
12:00-12:45
Plenary Lecture 3

Management of the Axilla in Patients Treated with Neoadjuvant Chemotherapy

Room 1 (Vista 1+2)
Moderators
  • Wonshik Han (Seoul National Univ. Hospital, Korea)
Speakers
  • Management of the Axilla in Patients Treated with Neoadjuvant Chemotherapy
    Judy Boughey (Mayo Clinic, U.S.A.)
13:00-13:45
Satellite Symposium 4
Room 1 (Vista 1+2)
Moderators
  • Jin-Hee Ahn (ASAN Medical Center, Korea)
Speakers
  • Pembrolizumab: Writing a New Chapter in eTNBC
    Jieun Lee (The Catholic Univ. of Korea, Seoul St. Mary's Hospital, Korea)
Satellite Symposium 5
Room 2 (Grand 1)
Moderators
  • Min-Ho Park (Chonnam National Univ. Hwasun Hospital, Korea)
Speakers
  • Time is Treatment: How PHESGO is Reshaping the HER2+ Breast Cancer Care
    Jee Hung Kim (Gangnam Severance Hospital, Korea)
14:00-14:45
Plenary Lecture 4

Tracking Triple Negative Breast Cancer Evolution and Immune Evasion: Insights from TRACERx

Room 1 (Vista 1+2)
Moderators
  • Joon Jeong (Gangnam Severance Hospital, Korea)
Speakers
  • Tracking Triple Negative Breast Cancer Evolution and Immune Evasion: Insights from TRACERx
    Charles Swanton (The Francis Crick Institute, United Kingdom)
15:00-15:50
Junior Doctors Forum
Room 4 (Walker 2)
Moderators
  • Ku Sang Kim (Kosin Univ. Gospel Hospital, Korea)
Speakers
  • The Key Points of Starting and Establishing an Institutional Database and Cohort Studies
    Nancy Lin (Dana-Farber Cancer Institute, U.S.A.)
  • The Experience of Being a Research Fellow Overseas
    Joon Jeong (Gangnam Severance Hospital, Korea)
15:00-16:15
Symposium 8

From Neoadjuvant to Adjuvant: Optimizing Post Neoadjuvant Systemic Therapy

Room 1 (Vista 1+2)
Moderators
  • Kyung Hae Jung (ASAN Medical Center, Korea)
  • Yen-Shen Lu (National Taiwan Univ. Hospital, Taiwan)
Speakers
  • Optimizing Adjuvant Treatment After Neoadjuvant Treatment in TNBC-ICI and Beyond
    In Hae Park (Korea Univ. Guro Hospital, Korea)
  • New Approach of Neoadjuvant & Adjuvant Treatment in HER2 Positive Breast Cancer - De-escalation and Novel Agents
    Yoon-Sim Yap (National Cancer Centre Singapore, Singapore)
  • Tailoring Neo & Adjuvant Treatment in HR Positive EBC
    Yen-Shen Lu (National Taiwan Univ. Hospital, Taiwan)
Panel Discussion 6

How Deep Impact of gBRCA1/2 Sequencing

Room 2 (Grand 1)
Moderators
  • Sung-Won Kim (Daerim St. Mary's Hospital, Korea)
  • Tira Tan (National Cancer Centre Singapore, Singapore)
Speakers
  • gBRCA1/2 Genes in Breast Cancer: Real-World Data and the Value of Universal Testing
    Hee Yeon Kim (Inje Univ. Busan Paik Hospital, Korea)
  • Endocrine-Resistant Breast Cancer in gBRCA Carriers
    Tira Tan (National Cancer Centre Singapore, Singapore)
  • Survival Analysis After Risk-Reducing Surgeries in BRCA Carriers with Breast Cancer
    Stephanie M. Wong (Jewish General Hospital Segal Cancer Centre, Canada)
Education Session 4

Antibody-Drug Conjugates in Clinical Practice: Bridging Innovation and Real-World Application

Room 3 (Walker 1)
Moderators
  • Jee Hyun Kim (Seoul National Univ. Bundang Hospital, Korea)
  • Jennifer Ligibel (Dana-Farber Cancer Institute, U.S.A.)
Speakers
  • From Development to Current Status: The Evolution of ADCs
    Jennifer Ligibel (Dana-Farber Cancer Institute, U.S.A.)
  • Beyond HER2 & TROP2: New Targets and Strategic Advances
    Kyong Hwa Park (Korea Univ. Anam Hospital, Korea)
  • Mechanisms of Resistance and Overcoming Strategies
    Sherene Loi (Univ. of Melbourne, Australia)
GBCC-SSO Joint Session

Treatment Strategies for Low-risk Ductal Carcinoma in Situ

Room 5 (Art Hall)
Moderators
  • Sung Yong Kim (Soonchunhyang Univ. Hospital Cheonan, Korea)
  • E. Shelley Hwang (Duke Univ. School of Medicine, U.S.A.)
Speakers
  • Surgical Treatment (Surveillance or Operation)
    E. Shelley Hwang (Duke Univ. School of Medicine, U.S.A.)
  • Endocrine Treatment (Omission or Medication)
    Jong Eun Lee (Soonchunhyang Univ. Hospital Cheonan, Korea)
  • Radiation Treatment (Omission or Radiotherapy)
    Haeyoung Kim (Samsung Medical Center, Korea)
16:05-17:45
Junior Doctors Debate
Room 4 (Walker 2)
Moderators
  • Tae-Kyung Robyn Yoo (ASAN Medical Center, Korea)
  • Tristen Park (Mount Sinai Hospital, U.S.A.)
Speakers
  • SNB Omission vs RT Omission in a Postmenopausal, 68YO Women with a cT1N0, G2, HR+HER2- Tumor
    Team 1 vs. Team 2TBD
  • Postmenopausal, 62YO Women had 2cm Calcification on Screening Mammography. Biopsy Diagnosed this as DCIS, Grade 2, ER/PR Positive, Minimal Risk Factors
    Team 3 vs. Team 4TBD
16:30-17:45
Symposium 9

From Genomics to Biomarker

Room 1 (Vista 1+2)
Moderators
  • Dong-Young Noh (CHA Gangnam Medical Center, Korea)
  • Charles Swanton (The Francis Crick Institute, United Kingdom)
Speakers
  • Mechanisms of Immune Evasion and Control in Breast Cancer
    Charles Swanton (The Francis Crick Institute, United Kingdom)
  • Molecular Determinants of CDK4/6 Inhibitor Response – What Have We Learned?
    Shom Goel (Peter MacCallum Cancer Centre and Univ. of Melbourne, Australia)
  • Biomarkers for Breast Cancer: Predictive vs. Prognostic; Clinical Validation vs. Clinical Utility
    Ben Ho Park (Vanderbilt Univ. Medical Center, U.S.A.)
Special Session

Clinical Controversy Session: Omission of SLNB in Early Breast Cancer

Room 2 (Grand 1)
Moderators
  • Olga Kantor (Dana-Farber Cancer Institute, U.S.A.)
Speakers
  • De-escalation of Axillary Staging: Lessons from Clinical Trials and Real-world Practice
    Wonshik Han (Seoul National Univ. Hospital, Korea)
  • Axillary Management in the Era of De-escalation: Radiation Oncologist's Perspective
    Hae Jin Park (Hanyang Univ. College of Medicine, Korea)
  • Less is More: Redefining Surgical Standards in Breast Cancer
    Bruce Mann (The Royal Women's Hospital, Australia)
  • Systemic Therapy Decision Making without Axillary Staging: A Medical Oncologist's Perspective
    Sung Hoon Sim (National Cancer Center, Korea)
Education Session 5

Breast Reconstruction and RT

Room 3 (Walker 1)
Moderators
  • Yong Bae Kim (Yonsei Cancer Center, Korea)
  • Huang Jian (The Second Affiliated Hospital of Zhejiang Univ. School of Medicine, China)
Speakers
  • Patient-Reported Outcome After Breast Reconstruction with RT
    Reshma Jagsi (Emory Univ., U.S.A.)
  • Evaluation and Management for Capsular Contracture
    Seung Yong Song (Yonsei Univ. College of Medicine, Korea)
  • Strategy to Minimize RT Toxicity
    Tae Hoon Lee (Samsung Medical Center, Korea)
GBCC-CACA Joint Session

New Developments in Systemic Management for High-Risk Early-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer

Room 5 (Art Hall)
Moderators
  • Airi Han (Yonsei Univ. Wonju College of Medicine, Korea)
  • Yongsheng Wang (Shandong Cancer Hospital & Institute, China)
Speakers
  • Risk Stratification in Early Breast Cancer Adjuvant Use of CDK4/6 Inhibitors
    Qiao Li (Cancer Hospital, Chinese Academy of Medical Science, China)
  • Risk Stratification in Early Breast Cancer: Who Truly Benefits from CDK4/6 Inhibition? (Biomarker Driven Approach)
    Soo Jung Lee (Kyungpook National Univ. Chilgok Hospital, Korea)
Panelists
  • Discussion
    Bo Chen (The First Affiliated Hospital of China Medical Univ., China)
  • Binbin Cong (Shandong Cancer Hospital & Institute, China)
  • Kwan Ho Lee (Kangbuk Samsung Hospital, Korea)
  • Sang Eun Nam (Konkuk Univ. Medical Center, Korea)
  • Yongsheng Wang (Shandong Cancer Hospital & Institute, China)
Back to Previous Meetings